Elevance Health, Inc. · NYSE:ELV
Elevance Health — Q3 2024 Earnings Presentation
13 slides from Elevance Health's earnings presentation, Oct 17, 2024
Slide 1: 3Q 2024 Earnings Presentation
Elevance Health 3Q 2024 Earnings Presentation October 17, 2024
Slide 2: Key Highlights
Key Highlights 1 3Q 2024 Results • • Elevance Health third quarter results were below expectations primarily due to the unprecedented mix shift in Medicaid membership related to eligibility redeterminations 3Q 2024 operating revenue of $44.7B grew 5.3% year-over-year • 3Q 2024 adjusted diluted EPS o
Slide 3: Enterprise Results 3Q 2024
Enterprise Results 3Q 2024 Results Key Highlights Elevance Health 3Q 2024 3Q 2023 Change • Elevance Health third quarter results reflect a challenging and dynamic Operating Revenue1 $44.7B $42.5B 5.3% operating environment primarily due to the timing mismatch between Medicaid rates and acuity Medica
Slide 4: Health Benefits 3Q 2024 Results
Health Benefits 3Q 2024 Results Key Highlights • Health Benefits revenue growth re- accelerating Health Benefits 3Q 2024 3Q 2023 Change • Operating revenue grew 4.2% driven primarily by higher premium yields, partially offset by declines in Operating Revenue1 $38.3B $36.7B 4.2% Medicaid membership •
Slide 5: Health Services 3Q 2024 Results
Health Services 3Q 2024 Results Key Highlights • Carelon is delivering innovative solutions aligned with our strategy of controlling the levers than matter Carelon 3Q 2024 3Q 2023 Change • Serves as the enterprise flywheel for growth, integrating physical, Operating Revenue1 $13.8B $12.0B 14.6% beha
Slide 6: Flywheel Supports Our Long-Term Growth Algorithm
Flywheel Supports Our Long-Term Growth Algorithm Health Benefits Health Services Approximately 46M medical members Optimize Invest in Integrated portfolio of whole health balanced across commercial, the Core Growth solutions connecting care across Medicaid and Medicare, leveraging physical, behavior
Slide 7: Long-Term Growth Algorithm
Long-Term Growth Algorithm Targeting at least 12% average annual growth in Adjusted Diluted EPS Adjusted Operating Gain – Upper Single Digit to Low Double Digit CAGR1 Revenue Growth Upper Single Digit CAGR1 + Adjusted Operating Margin Expanding to 6.5% - 7.0% by 2027 + Capital Deployment Approximate
Slide 8: Committed to Strong Growth Over the Long-Term
Committed to Strong Growth Over the Long-Term Health Benefits Carelon4 Elevance Health Dividends Upper Single 20% Mid to Upper Digit CAGR2,3 Single Digit CAGR2,3 $156B $138B M&A/ Organic Mid Teens Reinvestment CAGR2,3 Capital 50% Revenue1 $41B Allocation (in Billions) 2022 2027 2022 2027 2022 2027 T
Slide 9: Forward-Looking Statements
Forward-Looking Statements This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words su
Slide 10: Non-GAAP Measures and Basis of Presentation
Non-GAAP Measures and Basis of Presentation This document references non-GAAP measures. These non-GAAP measures are intended to aid investors when comparing Elevance Health’s financial results among periods and are not intended to be alternatives to any measure calculated in accordance with GAAP. Re
Slide 11: GAAP Reconciliation — Shareholders' Net Income and Earnings Per Diluted Share
Elevance Health GAAP Reconciliation — Shareholders’ Net Income and Shareholders’ Earnings Per Diluted Share Three Months Ended Sep 30 Nine Months Ended Sep 30 (In millions, except per share data) 2024 2023 Change 2024 2023 Change Shareholders' net income $1,016 $1,289 (21.2%) $5,562 $5,131 8.4% Add
Slide 12: GAAP Reconciliation — Operating Gain, Operating Expense Ratio, and 2024 Outlook
Elevance Health GAAP Reconciliation — Operating Gain, Operating Expense Ratio, and 2024 Outlook Three Months Ended Sep 30 Nine Months Ended Sep 30 (In millions) 2024 2023 Change 2024 2023 Change Reportable segments operating gain $1,408 $1,756 (19.8%) $7,189 $7,215 (0.4%) Add / (Subtract): Litigatio
Slide 13: Elevance Health
nw Elevance Health